CinRx Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $73M

CinRx Pharma General Information

Description

Provider of clinical development services intended to accelerate the progression of high-potential therapeutics. The company utilizes a hub-and-spoke operating model, centralized management framework, asset-focused portfolio companies, cross-functional expert teams, strategic cro partnership, and dynamic resource allocation, enabling biopharmaceutical companies to advance therapeutic candidates through clinical development and regulatory pathways.

Contact Information

Website
www.cinrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5375 Medpace Way
  • Cincinnati, OH 45227
  • United States
+1 (844)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 5375 Medpace Way
  • Cincinnati, OH 45227
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CinRx Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 30-May-2024 $73M Completed Clinical Trials - Phase 2
3. Later Stage VC 01-Jan-2020 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 28-Nov-2017 $10M $36M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Jul-2015 $26M $26M Completed Clinical Trials - Phase 2
To view CinRx Pharma’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CinRx Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of clinical development services intended to accelerate the progression of high-potential therapeutics. The com
Drug Discovery
Cincinnati, OH
19 As of 2025

New York, NY
 

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CinRx Pharma Competitors (4)

One of CinRx Pharma’s 4 competitors is Roivant Sciences, a Formerly PE-Backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Roivant Sciences Formerly PE-Backed New York, NY
BridgeBio Pharma Formerly VC-backed Palo Alto, CA
Centessa Pharmaceuticals Formerly VC-backed Altrincham, United Kingdom
Curie.Bio Venture Capital-Backed Boston, MA
To view CinRx Pharma’s complete competitors history, request access »

CinRx Pharma Patents

CinRx Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018165404-A1 Pharmaceutical formualtions of phloroglucinol and trimethylphloroglucinol Inactive 08-Mar-2017
AU-2018231044-A1 Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol Active 08-Mar-2017
AU-2018231044-A8 Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol Active 08-Mar-2017
AU-2018231044-B2 Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol Inactive 08-Mar-2017
CA-3053254-A1 Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol Active 08-Mar-2017 A61K9/1652
To view CinRx Pharma’s complete patent history, request access »

CinRx Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CinRx Pharma Investments (8)

CinRx Pharma’s most recent deal was a Joint Venture with CinRock Pharma. The deal was made on 02-Nov-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
CinRock Pharma 02-Nov-2026 Joint Venture Drug Discovery
CinDome Pharma 16-May-2024 Later Stage VC Drug Discovery
vTv Therapeutics 25-Jul-2022 PIPE Biotechnology
CinCor Pharma 22-Sep-2021 Early Stage VC Drug Discovery
CinFina Pharma 01-Jan-2021 Corporate Drug Discovery
You’re viewing 5 of 8 investments. Get the full list »

CinRx Pharma FAQs

  • When was CinRx Pharma founded?

    CinRx Pharma was founded in 2015.

  • Where is CinRx Pharma headquartered?

    CinRx Pharma is headquartered in Cincinnati, OH.

  • What is the size of CinRx Pharma?

    CinRx Pharma has 19 total employees.

  • What industry is CinRx Pharma in?

    CinRx Pharma’s primary industry is Drug Discovery.

  • Is CinRx Pharma a private or public company?

    CinRx Pharma is a Private company.

  • What is CinRx Pharma’s current revenue?

    The current revenue for CinRx Pharma is .

  • How much funding has CinRx Pharma raised over time?

    CinRx Pharma has raised $176M.

  • Who are CinRx Pharma’s competitors?

    Roivant Sciences, BridgeBio Pharma, Centessa Pharmaceuticals, and Curie.Bio are competitors of CinRx Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process